134 related articles for article (PubMed ID: 28522578)
1. Mutated
Valencia-Martinez A; Sanna A; Masala E; Contini E; Brogi A; Gozzini A; Santini V
Haematologica; 2017 Sep; 102(9):e332-e335. PubMed ID: 28522578
[No Abstract] [Full Text] [Related]
2. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
Boultwood J; Perry J; Pellagatti A; Fernandez-Mercado M; Fernandez-Santamaria C; Calasanz MJ; Larrayoz MJ; Garcia-Delgado M; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Hellström-Lindberg E; Cazzola M; Wainscoat JS
Leukemia; 2010 May; 24(5):1062-5. PubMed ID: 20182461
[No Abstract] [Full Text] [Related]
3. Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis.
Lin Y; Zheng Y; Wang ZC; Wang SY
Hematology; 2016 Sep; 21(8):454-61. PubMed ID: 27077763
[TBL] [Abstract][Full Text] [Related]
4. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Gelsi-Boyer V; Trouplin V; Adélaïde J; Bonansea J; Cervera N; Carbuccia N; Lagarde A; Prebet T; Nezri M; Sainty D; Olschwang S; Xerri L; Chaffanet M; Mozziconacci MJ; Vey N; Birnbaum D
Br J Haematol; 2009 Jun; 145(6):788-800. PubMed ID: 19388938
[TBL] [Abstract][Full Text] [Related]
5. ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS.
Sallman DA; Komrokji R; Cluzeau T; Vaupel C; Al Ali NH; Lancet J; Hall J; List A; Padron E; Song J
Blood Cancer J; 2017 Nov; 7(12):633. PubMed ID: 29176559
[No Abstract] [Full Text] [Related]
6. ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia.
Padron E; Yoder S; Kunigal S; Mesa T; Teer JK; Al Ali N; Sekeres MA; Painter JS; Zhang L; Lancet J; Maciejewski JP; Epling-Burnette PK; Sotomayor E; Komrokji RS; List AF
Blood; 2014 Jun; 123(23):3675-7. PubMed ID: 24904105
[No Abstract] [Full Text] [Related]
7. [Role of ASXL1 mutation in myeloid malignancies].
Sheng MY; Zhou Y; Xu MJ; Yang FC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1183-7. PubMed ID: 25130853
[TBL] [Abstract][Full Text] [Related]
8. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
Gelsi-Boyer V; Trouplin V; Roquain J; Adélaïde J; Carbuccia N; Esterni B; Finetti P; Murati A; Arnoulet C; Zerazhi H; Fezoui H; Tadrist Z; Nezri M; Chaffanet M; Mozziconacci MJ; Vey N; Birnbaum D
Br J Haematol; 2010 Nov; 151(4):365-75. PubMed ID: 20880116
[TBL] [Abstract][Full Text] [Related]
9. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
Elliott MA; Pardanani A; Hanson CA; Lasho TL; Finke CM; Belachew AA; Tefferi A
Am J Hematol; 2015 Jul; 90(7):653-6. PubMed ID: 25850813
[TBL] [Abstract][Full Text] [Related]
10. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
11. PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia.
Bataller A; Chien KS; Sasaki K; Montalban-Bravo G; Kanagal-Shamanna R; Urrutia S; Almanza-Huante E; Gener-Ricos G; Ravandi F; Jabbour E; Kadia T; Borthakur G; Garcia-Manero G
Leuk Res; 2023 Apr; 127():107044. PubMed ID: 36801700
[No Abstract] [Full Text] [Related]
12. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
13. Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia.
Cervera N; Itzykson R; Coppin E; Prebet T; Murati A; Legall S; Vey N; Solary E; Birnbaum D; Gelsi-Boyer V
Am J Hematol; 2014 Jun; 89(6):604-9. PubMed ID: 24595958
[TBL] [Abstract][Full Text] [Related]
14. ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26.
Perez Botero J; Oliveira JL; Chen D; Reichard KK; Viswanatha DS; Nguyen PL; Pruthi RK; Majerus J; Gada P; Gangat N; Tefferi A; Patnaik MM
Blood Cancer J; 2015 May; 5(5):e315. PubMed ID: 26001113
[No Abstract] [Full Text] [Related]
15. EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental.
Patnaik MM; Vallapureddy R; Lasho TL; Hoversten KP; Finke CM; Ketterling R; Hanson C; Gangat N; Tefferi A
Blood Cancer J; 2018 Jan; 8(1):12. PubMed ID: 29358618
[No Abstract] [Full Text] [Related]
16. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.
West RR; Hsu AP; Holland SM; Cuellar-Rodriguez J; Hickstein DD
Haematologica; 2014 Feb; 99(2):276-81. PubMed ID: 24077845
[TBL] [Abstract][Full Text] [Related]
17. Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish.
Fang X; Xu S; Zhang Y; Xu J; Huang Z; Liu W; Wang S; Yen K; Zhang W
Leukemia; 2021 Aug; 35(8):2299-2310. PubMed ID: 33483612
[TBL] [Abstract][Full Text] [Related]
18. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
Damm F; Itzykson R; Kosmider O; Droin N; Renneville A; Chesnais V; Gelsi-Boyer V; de Botton S; Vey N; Preudhomme C; Clavert A; Delabesse E; Park S; Birnbaum D; Fontenay M; Bernard OA; Solary E
Leukemia; 2013 Jun; 27(6):1401-3. PubMed ID: 23443343
[No Abstract] [Full Text] [Related]
19. Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations.
Micol JB; Abdel-Wahab O
Haematologica; 2014 Feb; 99(2):201-3. PubMed ID: 24497555
[No Abstract] [Full Text] [Related]
20. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
Pérez B; Kosmider O; Cassinat B; Renneville A; Lachenaud J; Kaltenbach S; Bertrand Y; Baruchel A; Chomienne C; Fontenay M; Preudhomme C; Cavé H
Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
